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Background:  The  Measles  & Rubella  Initiative,  a broad  consortium  of  global  health  agencies,  has  provided
support  to  measles-burdened  countries,  focusing  on sustaining  high coverage  of routine  immunization  of
children  and  supplementing  it with  a second  dose  opportunity  for  measles  vaccine  through  supplemental
immunization  activities  (SIAs).  We  estimate  optimal  scheduling  of SIAs  in  countries  with  the  highest
measles  burden.
Methods:  We  develop  an  age-stratiﬁed  dynamic  compartmental  model  of  measles  transmission.  We
explore  the frequency  of  SIAs  in order  to  achieve  measles  control  in selected  countries  and  two  Indian
states  with  high  measles  burden.  Speciﬁcally,  we  compute  the maximum  allowable  time  period  between
two  consecutive  SIAs  to achieve  measles  control.
Results: Our  analysis  indicates  that  a single  SIA will not  control  measles  transmission  in  any  of  theow- and middle-income settings
hild health
athematical modeling
countries  with  high  measles  burden.  However,  regular  SIAs  at high  coverage  levels  are  a viable  strategy
to  prevent  measles  outbreaks.  The  periodicity  of  SIAs  differs  between  countries  and  even  within  a single
country,  and  is  determined  by population  demographics  and  existing  routine  immunization  coverage.
Conclusions:  Our  analysis  can  guide  country  policymakers  deciding  on the optimal  scheduling  of SIA
campaigns  and  the  best  combination  of  routine  and  SIA vaccination  to control  measles.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
The fourth United Nations Millennium Development Goal aims
o reduce under-ﬁve mortality rates by two thirds between 1990
nd 2015. Despite accelerated progress, with a decline from about
2 million deaths in 1990 to about 7–8 million deaths in 2010,
he goal is unlikely to be attained at current rates of decline
1–3]. Measles has been a key contributor to this mortality.
lthough measles mortality has dropped globally, from up to 5%
∗ Corresponding author at: Department of Global Health and Population, Harvard
.H. Chan School of Public Health, Boston, MA,  USA.
E-mail address: verguet@hsph.harvard.edu (S. Verguet).
ttp://dx.doi.org/10.1016/j.vaccine.2014.11.050
264-410X/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unof under-ﬁve deaths in 2000 [2,4,5] to about 1–2% in 2010 [2,3],
measles burden remains high in a number of countries [6]. The
Measles & Rubella Initiative (www.measlesrubellainitiative.org),
a broad consortium of global health agencies, has provided sup-
port to measles-burdened countries in order to sustain and achieve
measles mortality reductions. It has been focusing on maintaining
high coverage of routine immunization of children at about 9 or
12 months of age and supplementing it by a recommended second
dose for measles vaccine [7–9]. In a large number of countries, the
second dose of measles vaccine is usually included in the vaccina-
tion schedule and usually administered to children before school
entry [8]. In high measles-burdened countries, often, only one
dose is routinely given, but an opportunity for a second dose of
measles vaccine is offered through supplemental immunization
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1 cine 33 (2015) 1291–1296
a
t
t
u
t
[
m
t
m
b
a
m
4
l
c
T
O
S
c
r
i
[
a
d
f
i
i
f
a
F
i
m
W
c
e
a
m
m
m
d
i
a
2
2
c
t
u
m
i
p
t
d
m
m
t
o
m
s
Fig. 1. Model of vaccine action. Note: S = susceptible, I = infected, R = recovered,
VS = vaccinated susceptible, VI = vaccinated infected, VR = vaccinated recovered,
  = force of infection,  = infectiousness period of measles,  = coverage of measles
vaccine for individuals vaccinated for the 1st time,  = effectiveness of measles vac-
cine (85% for the ﬁrst dose when vaccinating before one year of age, 95% after one292 S. Verguet et al. / Vac
ctivities (SIAs) [8,9]. During SIAs, children and adolescents are
argeted regardless of their previous history of measles vaccina-
ion. Periodic SIA campaigns occur nationally/sub-nationally with
se of various outreach strategies [9].
World Health Organization (WHO) analysts have reported sus-
ained decreases in measles mortality worldwide since the 2000s
6,10]; most recently, global measles-related deaths were esti-
ated to have decreased from about 535,000 deaths in 2000
o 140,000 deaths in 2010 [6]. Despite these global reductions,
easles mortality remains substantial and concentrated in a num-
er of high measles-burdened countries [2,3,6]. For example, India
ccounted for almost 50% (about 65,000 deaths) of estimated
easles mortality in 2010, and the WHO  Africa region for almost
0% (about 50,000 deaths) [6,11]. Some of these countries have
ow levels of routine immunization, such as Nigeria with a 42%
overage rate for the ﬁrst dose of measles vaccine (MCV1) [12].
hat being said, experience from ﬁrst the Pan American Health
rganization (PAHO) and then sub-Saharan Africa has shown that
IAs can contribute to achieving measles control in high burden
ountries. Indeed, large-scale implementation of SIAs in the PAHO
egion since the 1990s is thought to have contributed to the elim-
nation of the endemic transmission of measles in the Americas
13]. The same strategy has been adapted to sub-Saharan Africa and
ppeared as a major contributor for the reported drops in measles
eaths on the African continent over the last decade [14,15]. There-
ore, it is necessary to examine the optimal strategies that can be
mplemented in order to control measles in high burden countries;
n particular, it is important to determine the appropriate use and
requency of periodic SIAs in these countries.
High measles-burden countries with limited ﬁnancial resources
re confronted with difﬁcult decisions related to measles control.
or example, these decisions involve sensitive trade-offs between
nvesting in sustainable routine immunization services and imple-
enting repeated SIAs, as part of the overall strategy. In particular,
HO  recommends SIAs to be repeated every 2–4 years for those
ountries with MCV1 coverage below 80% [8]. In this paper, we
xamined the trade-offs between routine vaccination coverage
nd SIA coverage and inter-SIA periodicity in order to achieve
easles control. Speciﬁcally, we selected countries with the highest
easles mortality burden globally [2,3], and estimated the opti-
al  scheduling of future measles SIAs in these countries, using a
ynamic compartmental model of measles transmission. The aim
s to inform country policymakers about the scheduling of SIAs to
chieve measles control.
. Methods
.1. Modeling
We  developed DynaMICE (Dynamic Measles Immunization Cal-
ulation Engine), an age-stratiﬁed model of measles infection
ransmission in vaccinated and unvaccinated individuals. The pop-
lation in the model can be susceptible to measles, infected with
easles or recovered from measles (and hence have lifelong
mmunity). The rate at which infection occurs in the susceptible
opulation depends on the existing proportion of the population
hat is already infected, as well as the effective contact rate between
ifferent age groups. Individuals age discretely, in one-year incre-
ents, at the end of each year [16], between 0 and 100 years old.
Vaccinated individuals are assumed to have a reduced risk of
easles infection. Vaccine effectiveness is assumed to be 85% for
he ﬁrst dose when vaccinating before one year of age, 95% after
ne year of age and 98% for two doses, as suggested by a recent
eta-analysis [17]. Vaccines are assumed to be “all or nothing” [18],
o that individuals receiving the vaccine are either fully protectedyear of age and 98% for two doses), 2 = coverage of measles vaccine for individuals
vaccinated for the 2nd time, through supplemental immunization activity (SIA) only
(SIA coverage).
or not at all (Fig. 1). We assume that vaccination gives lifetime
protection if it successfully elicits an immune response, and that
vaccinating already infected individuals does not increase the rate
of infection clearance (i.e. the vaccine has no therapeutic action).
The model was  programmed using R statistical software version
3.0.1 (www.r-project.org). Mathematical equations describing the
model are provided in the Supplementary Data (Section 1). More
details can be obtained from the authors upon request.
2.2. Model parameters
Dynamic models of infection transmission require data on age-
dependent contact patterns in the population. However, empirical
data on contacts have been published for only several European
countries and Vietnam. We  used well established contact sur-
vey data from Great Britain [19] corresponding to a probability of
transmission per contact of about 3%, and in a sensitivity analy-
sis, used mixing patterns from Vietnam [20]. The probability of an
infected individual transmitting measles to a susceptible individ-
ual following an effective contact was  set to be consistent with a
basic reproduction number (R0, the number of people infected by a
single infected person in a completely susceptible population) for
measles of 16 [21]. We  also changed R0 to the lower value of 12 in
a sensitivity analysis.
The selected countries with high measles mortality bur-
den retained were: India, Ethiopia, Nigeria, Indonesia, Mali,
Afghanistan, Niger, Madagascar, and Burkina Faso. These countries
were selected among the ten countries with the highest estimated
burden of measles from each of two sources of estimates: the Child
Health Epidemiology Reference Group of WHO  and UNICEF [3]
and the Institute for Health Metrics and Evaluation [2]. The pop-
ulation age distribution by country was sourced from the United
Nations, along with crude birth rates and death rates by country
[22]; these demographic parameters were assumed to be static
over time (constant population growth) to simplify long-term
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opulation projections. The average infectious period of measles
as assumed to be 14 days [21]. MCV1 was assumed to be deliv-
red before the ﬁrst birthday, with the SIA measles dose being given
o all children between six months and ﬁve years old, assuming for
implicity that vaccination could be given as maternally derived
mmunity had waned. In practice, this may  be an approximation
ince the lower age limit is commonly 9 or 12 months, which is
 few months after these antibodies may  have waned.1 The prob-
bility of receiving a MCV1 and SIA dose was assumed to be
ncorrelated. MCV1 coverage by country was obtained from WHO
nd UNICEF [12]. Coverage ﬁgures for the SIAs were assumed to
e of 90% among the 6–59 month-olds, a conservative estimate
ccording to historical SIA coverage data collated by WHO  [23].
.3. Model analysis
The dynamic compartmental model developed and presented
bove was run for 100 years with routine vaccination to reach a
ost-vaccination equilibrium (the last 50 years of which are shown
n Fig. 2), and ﬁnally run for a further 50 years with both rou-
ine and SIA vaccination. Using country-speciﬁc inputs (e.g. MCV1
overage), we explored the potential periodicity of SIAs required
n order to achieve measles control. Disease control refers to the
eduction of morbidity and mortality to locally acceptable levels
24]. Here we deﬁne measles as being controlled if the incidence
f measles remains below 1 per 100,000 individuals in the entire
opulation.
.4. Analytical approach
The computer model presented above requires considerable
echnical capacity and computing power. To enable policymakers
o use our model for SIA planning with greater ease, we also derived
 simple formula relating SIA periodicity to immunization cover-
ge and population demographics. To do this, we simpliﬁed the
ystem of differential equations representing the model of measles
ransmission (Supplementary Data, Section 1), removing age strat-
ﬁcation in order to make the equations analytically tractable [25].
his allowed us to compute the maximum time period allowed
etween two consecutive SIAs that would still achieve measles
ontrol, depending on MCV1 coverage, demographic parameters,
easles speciﬁc parameters, and vaccine effectiveness. The max-
mum inter-SIA period allowed to achieve measles control could
hen be estimated as (with the formula developed in Supplemen-
ary Data, Section 2):
max∼
SS,eff
˜R0(1 − RR)(1 − SS,eff /2)
(1)
here R0 is the basic reproduction number, v˜ is the birth rate
djusted for population growth (birth rate multiplied by the ratio
etween under-ﬁve population and 5–9-year-olds population), R
nd S are the effectiveness of MCV1 and SIA measles vaccine
espectively, R is the coverage of MCV1, and S,eff is the effec-
ive coverage of SIA immunization (90% coverage multiplied by the
raction of measles cases among under-ﬁves depending on MCV1
overage and as estimated by geographical region [6]). The com-
lete details of this approach are given in the Supplementary Data
Section 2).
. ResultsFig. 2 shows results from the computer simulation showing
hange in the number of infected individuals (measles incidence)
1 This choice does not materially affect the measles dynamics studied in the paper.3 (2015) 1291–1296 1293
following the implementation of SIAs at regular time intervals from
every single year to every 10 years (dotted vertical lines), with
MCV1 coverage of 74% and with the population structure of India.
In this case, we see that there is resurgence of measles (occurrence
of incidence peaks after year 50) when the inter-SIA period is over
three years. Furthermore, the less frequent the SIA, the larger the
resurgence. Conversely, an average inter-SIA period of three years
or less sufﬁces to control measles (no occurrence of incidence peaks
after year 50).
Table 1 also lists the inter-SIA periods required in order to
achieve measles control, estimated computationally, for selected
countries with high measles burden and 90% SIA coverage among
6–59 month-olds. We  see that the maximum time period required
between two consecutive SIAs depends importantly on MCV1
coverage (Pearson correlation coefﬁcient of 0.71). For example,
countries like Ethiopia and Nigeria with lower coverage of MCV1
(66% and 42%, respectively) would require SIAs about every 2 years.
This national picture may  however mask heterogeneities at
the sub-national/state level and Table 1 also lists the periodicity
required between SIAs in order to achieve measles control with
current level of MCV1 coverage for two Indian states, Bihar and
Uttar Pradesh, where SIAs have been undertaken since 2010 and
2011, respectively. For these two  states, we see that the inter-SIA
period required is 2 years compared with 3 years at the national
level.
This computational analysis is further conﬁrmed by the analyt-
ical results, also presented in Table 1. Based on Eq. (1) above, Fig. 3
shows the inter-SIA period required to achieve measles control for
a range of SIA coverage levels, as a function of MCV1 coverage
levels, using Indian demographic inputs and R0 of 16. In the last
column of Table 1, the results are shown for the inter-SIA period
required in order to achieve measles control, estimated analytically
through Eq. (1) and rounded down,2 for 90% SIA coverage among
6–59 month-olds. We  see that these analytical results match the
simulation results closely.
Finally, in the simulation model, the use of mixing data from
Vietnam [20] would lengthen the measles inter-epidemic cycles
considerably and increase the height of the epidemic peaks, leading
to unrealistic inter-epidemic cycles much larger than the 1–2 year
cycles usually expected in low- and middle-income countries with
higher birth rates and lower MCV1 coverage [21,26,27]. Although
this is not clear, reasons for this difference may  include less assorta-
tive mixing (due to differences in household structure and/or birth
rates) or recall bias.
In addition, we  varied the basic reproduction number for sensi-
tivity analysis. Table 2 reports on the inter-SIA period required in
order to achieve measles control, estimated computationally and
analytically, for the selected countries with high measles burden,
with 90% SIA coverage among 6–59 month-olds, and with a lower
reproduction number R0 of 12, in order to highlight a better case
scenario. Expectedly, we  see that the inter-SIA period to achieve
measles control is increased on average for all countries.
4. Discussion
Both numerical simulation and mathematical analysis indicate
that a single SIA will not control measles outbreaks in any of the
countries with high burden of measles. However, regular SIAs atperiodicity of SIA campaigns determined by population demo-
graphics and existing MCV1 coverage.
2 Rounding down (e.g. 2.3∼2; 2.7∼2) the inter-SIA period estimated analytically
leads to a more conservative estimate.
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quilibrium (the last 50 years of which are shown), and ﬁnally run for a further 50 
The model also suggests that a single SIA may  give the impres-
ion of having controlled measles due to a post-vaccination
honeymoon’ [28] (Fig. 2). Such potentially unexpected effects can
ave disastrous consequences on plans for national elimination
r even global eradication goals. This underscores the importance
f using predictive models that account for transmission events,
ather than relying solely on surveillance based on reported cases,
o inform decision making about vaccination.
Several models of measles transmission have been previously
eveloped in order to explore the potential impact of different
accination strategies [27,29–35], including the impact of massia, under different intervals between SIAs. Each SIA is indicated by a dotted vertical
he model was run for 100 years with routine vaccination to reach a postvaccination
with both routine and SIA vaccination.
immunization campaigns [25,36–38]. Here, we  build on these mod-
els to explore the impact and optimal timing of periodic measles
immunization campaigns, which have been the main focus of
measles control efforts in the highest burden countries. We  ﬁnd
that impact and optimal timing of measles SIAs varied among
the highest burden countries, and even within a single country
(Tables 1 and 2). This suggests that a country-speciﬁc approach
to SIA timing may  be most effective, with the recommended
length of time between SIAs dependent on local demographics and
routine coverage. Our computer model and the associated simpli-
ﬁed analytical formula offer a way  for country policymakers to
S. Verguet et al. / Vaccine 33 (2015) 1291–1296 1295
Table  1
Inter-SIA period required to achieve measles control with 90% SIA coverage and R0 of 16, as a function of routine immunization coverage for the ﬁrst dose of measles vaccine
and  crude birth rate, for selected countries with high measles burden, and two  Indian states.
Country Routine coverage for 1st
dose of measles vaccine (%)
Crude birth rate (per
1000 population)
SIA period (years)
(computational model)
SIA period (years)
(analytical model)
Afghanistan 68 36 2 2
Burkina Faso 87 43 3 3
Ethiopia 66 35 2 2
India  74 23 3 3
State  of Bihar 58 29 2 3
State  of Uttar Pradesh 53 29 2 2
Indonesia 80 21 3 4
Madagascar 69 36 2 2
Mali  59 49 2 2
Niger  73 51 
Nigeria 42 43 
Table 2
Supplemental immunization activity (SIA) period required to achieve measles con-
trol with 90% SIA coverage and R0 of 12, for selected countries with high measles
burden, and two Indian states.
Country SIA period (years)
(computational model)
SIA period (years)
(analytical model)
Afghanistan 3 3
Burkina Faso 5 5
Ethiopia 3 3
India 3 4
State of Bihar 3 4
State of Uttar Pradesh 2 3
Indonesia 4 6
Madagascar 3 3
d
a
t
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h
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d
rMali 3 3
Niger 3 3
Nigeria 2 3
etermine when measles SIAs should be implemented. They can
lso further inform WHO  guidelines on the conduct of SIAs at
he country level, by recommending speciﬁc inter-SIA periods to
chieve measles control at the national and sub-national levels,
epending on a range of country-speciﬁc routine immunization
overage rates and demography, and including within country
eterogeneities. Our analysis highlights country inter-SIA periods
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90%
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ig. 3. Inter-SIA period (years) as a function of routine immunization coverage for
he ﬁrst dose of measles vaccine, for different levels of SIA coverage with Indian
emographic inputs and R0 of 16. Note: the dotted vertical line depicts the current
outine immunization coverage for the ﬁrst dose of measles vaccine in India (74%).2 2
2 2
within the range of the 2–4 years periods recommended by WHO
for countries with MCV1 coverage under 80% [8]. But, it also goes
beyond these recommendations as it provides a means to weigh
various combinations of coverage levels for MCV1 and SIAs with
the dimension of SIA periodicity. This enables countries to identify
more locally appropriate SIA scheduling in accordance with ﬁnan-
cial and operational capacity: this is especially important in the
context of resource-limited settings given that SIAs can be expen-
sive.
Nonetheless, our model has several limitations. First, we used an
average estimate of the basic reproduction number of measles, and
hence did not capture local variations in the intensity of measles
transmission (due to differences in cultural practices and social
gathering, for example). However, estimating this number sepa-
rately for each setting is hindered by the lack of reliable data for
measles case notiﬁcations due to underreporting and great dis-
parity in reporting quality. As sensitivity analysis, we reported
on the inter-SIA period required for the selected high burden
countries with a lower reproduction number R0 of 12 (Table 2).
Also, in the absence of data, we  did not account for potential
variations in vaccine effectiveness at the country/region level. Sec-
ond, due to lack of data, the model does not take into account
potential correlation between MCV1 and SIA coverage, and the
fact that often children with better access to health systems and
hence more likely to have received MCV1 can be easier to reach
through SIA. Neither does it account for changes in immunization
and birth rates into the future, as these are largely uncertain to
forecast. Finally, though the model captures the conditions neces-
sary for measles control, it is not intended to realistically model
measles elimination (i.e. zero indigenous transmission events).
Elimination goals depend on monitoring measles importations,
vaccine coverage in hard-to-reach groups and stochastic one-off
events, none of which are captured by the model (and rarely so
by most models published in the literature). One could however
examine the potential of an imported case to invade the popula-
tion.
Despite these limitations, the broad conclusions of the model
appear robust, particularly the need for regular SIAs to control
measles in low routine coverage settings as in many high-
endemicity countries. Models such as the one presented here
are important tools for vaccination decision making, comple-
menting existing information from surveillance systems. Our
ﬁndings generally substantiate the guidance given by WHO, but
most importantly can be used by country policymakers to tailor
their SIA scheduling and planning to their speciﬁc setting, tak-
ing into account local demographics and routine coverage. As a
result, countries with longer estimated inter-SIA periods might
consider further investments in routine immunization services,
whereas those with shorter inter-SIA periods may postpone such
investments. Since measles control and elimination strategies are
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omplex and require considerable ﬁnancial investments, optimi-
ing country planning of measles activities is critical. This model
rovides a valuable and practical tool for high measles-burdened
ountries toward efﬁcient resource allocation in order to achieve
easles control.
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